C. Poreaux

Non‐irritant concentrations and amounts of active ingredient in drug patch tests

D. Brajon, Sophie Ménétré, J. Waton et al. · Contact Dermatitis · 2014 · 43 citations

Life Sciences, Pharmacology, Allergy +13

Managing generalized interferon‐induced eruptions and the effectiveness of desensitization

C. Poreaux, J.‐P. Bronowicki, Marc Debouverie et al. · Clinical & Experimental Allergy · 2013 · 20 citations

Life Sciences, Dermatology, Pharmacology +17

IgE antibodies and skin tests in immediate hypersensitivity reactions to infliximab in inflammatory bowel disease

E. Fréling, Laurent Peyrin‐Biroulet, C. Poreaux et al. · European Journal of Gastroenterology & Hepatology · 2015 · 19 citations

Life Sciences, Immunology, Pharmacotherapy +17

Prevalence of ocular disease during dupilumab treatment for atopic dermatitis: a bicentric retrospective comparative cohort study

J Barbé, C. Poreaux, Thomas Rémen et al. · International Journal of Dermatology · 2021 · 14 citations

Medicine, Dermatology, Ophthalmology +13

Evolution of dupilumab‐associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (<scp>RESO</scp>‐<scp>ADOC</scp> study)

Z. Reguiaï, Pierre André Becherel, C. Boulard et al. · Journal of the European Academy of Dermatology and Venereology · 2024 · 13 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17